In synovial tissues of RA patients, the increased expression of KAT2A promotes the inducible transcription of Il1b and Nlrp3 genes by catalyzing H3K9ac and limiting NRF2 activation, thereby leading to uncontrolled IL‐1β production and inflammatory injury in RA progression. Here, KAT2A is linked to rheumatoid arthritis.